CME Group (CME) Stock Forecast & Price Target

Compare

1,908 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CME Analyst Ratings

Moderate Buy

6 Buy

4 Hold

2 Sell

Based on 12 analysts giving stock ratings to

CME

Group

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CME Stock 12 Month Forecast

Average Price Target

$286.33

▲(5.18% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for CME Group in the last 3 months. The average price target is $286.33 with a high forecast of $313.00 and a low forecast of $212.00. The average price target represents a 5.18% change from the last price of $272.24.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"204":"$204","259":"$259","314":"$314","231.5":"$231.5","286.5":"$286.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":313,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$313.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":286.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$286.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":212,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$212.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[204,231.5,259,286.5,314],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,264.14,267.8984615384615,271.6569230769231,275.4153846153846,279.17384615384617,282.9323076923077,286.6907692307692,290.4492307692308,294.2076923076923,297.9661538461538,301.7246153846154,305.4830769230769,309.2415384615385,{"y":313,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,264.14,265.8469230769231,267.55384615384617,269.2607692307692,270.9676923076923,272.6746153846154,274.38153846153847,276.0884615384615,277.7953846153846,279.5023076923077,281.20923076923077,282.9161538461538,284.6230769230769,{"y":286.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,264.14,260.12923076923073,256.11846153846153,252.1076923076923,248.09692307692308,244.08615384615385,240.07538461538462,236.06461538461537,232.05384615384617,228.0430769230769,224.0323076923077,220.02153846153846,216.01076923076923,{"y":212,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":205.45,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":215.66,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":214.06,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":225.55,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.94,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.17,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.17,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":259.8,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274.53,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":288.01,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274.11,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":279.42,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":264.14,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$313.00

Average Price Target$286.33

Lowest Price Target$212.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Christopher Allen

Citi

$275→$300

Buy

10.20%

Upside

Upgraded

09/26/25

CME Group upgraded to Buy from Neutral at CitiCME Group upgraded to Buy from Neutral at Citi

Clio Chartessa

TR | OpenAI - 4o

$306→$305

Buy

12.03%

Upside

Reiterated

09/26/25

AI Generated ArticleAI Generated Article

Ken Worthington

J.P. Morgan

$246→$252

Sell

-7.43%

Downside

Reiterated

09/25/25

CME Group (CME) Gets a Sell from J.P. MorganCME Group Inc. (Underweight; Price Target: $252.00)

Ashish Sabadra

RBC Capital

$282

Hold

3.59%

Upside

Reiterated

09/11/25

Analysts' Opinions Are Mixed on These Financial Stocks: CME Group (NASDAQ: CME), Charles Schwab (NYSE: SCHW) and OneMain Holdings (NYSE: OMF)

Alex Kramm

UBS

$305→$285

Hold

4.69%

Upside

Reiterated

09/08/25

CME Group price target lowered to $285 from $305 at UBSCME Group price target lowered to $285 from $305 at UBS

Kyle Voigt

KBW

$283

Hold

3.95%

Upside

Reiterated

09/04/25

CME Group (CME) Gets a Hold from KBW

Patrick Moley

Piper Sandler

$296

Buy

8.73%

Upside

Reiterated

08/04/25

CME Group (CME) Gets a Buy from Piper Sandler

Benjamin Budish

Barclays

$299→$298

Hold

9.46%

Upside

Reiterated

07/24/25

CME Group (CME) Receives a Rating Update from a Top Analyst

Owen Lau

Oppenheimer

$300→$303

Buy

11.30%

Upside

Reiterated

07/24/25

Oppenheimer Sticks to Their Buy Rating for CME Group (CME)Raised our PT to $303 from $300.

Michael Cyprys

Morgan Stanley

$304→$303

Buy

11.30%

Upside

Reiterated

07/24/25

Positive Outlook for CME Group Driven by Risk Management Demand and Strong Financial Position

Craig Siegenthaler

Bank of America Securities

$213→$212

Sell

-22.13%

Downside

Reiterated

07/23/25

Bank of America Securities Sticks to Its Sell Rating for CME Group (CME)

Patrick O'Shaughnessy

Raymond James

$306→$309

Buy

13.50%

Upside

Reiterated

07/23/25

CME Group (CME) Gets a Buy from Raymond JamesRaymond James analyst Patrick O\\\Shaughnessy raised the price target on CME Group (NASDAQ: CME) to $309.00 (from $306.00) while maintaining a Outperform rating.

Daniel Fannon

Jefferies

$288→$313

Buy

14.97%

Upside

Reiterated

07/14/25

CME Group (CME) PT Raised to $313 at JefferiesJefferies analyst Daniel Fannon raised the price target on CME Group (NASDAQ: CME) to $313.00 (from $288.00) while maintaining a Buy rating.

Hans Engel

Erste Group

―

Hold

―

Downgraded

05/23/25

CME Group downgraded to Hold from Buy at Erste GroupCME Group downgraded to Hold from Buy at Erste Group

Kevin Heal

Argus Research

$285→$308

Buy

13.14%

Upside

Reiterated

05/06/25

CME Group price target raised to $308 from $285 at ArgusCME Group price target raised to $308 from $285 at Argus

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Christopher Allen

Citi

$275→$300

Buy

10.20%

Upside

Upgraded

09/26/25

CME Group upgraded to Buy from Neutral at CitiCME Group upgraded to Buy from Neutral at Citi

Clio Chartessa

TR | OpenAI - 4o

$306→$305

Buy

12.03%

Upside

Reiterated

09/26/25

AI Generated ArticleAI Generated Article

Ken Worthington

J.P. Morgan

$246→$252

Sell

-7.43%

Downside

Reiterated

09/25/25

CME Group (CME) Gets a Sell from J.P. MorganCME Group Inc. (Underweight; Price Target: $252.00)

Ashish Sabadra

RBC Capital

$282

Hold

3.59%

Upside

Reiterated

09/11/25

Analysts' Opinions Are Mixed on These Financial Stocks: CME Group (NASDAQ: CME), Charles Schwab (NYSE: SCHW) and OneMain Holdings (NYSE: OMF)

Alex Kramm

UBS

$305→$285

Hold

4.69%

Upside

Reiterated

09/08/25

CME Group price target lowered to $285 from $305 at UBSCME Group price target lowered to $285 from $305 at UBS

Kyle Voigt

KBW

$283

Hold

3.95%

Upside

Reiterated

09/04/25

CME Group (CME) Gets a Hold from KBW

Patrick Moley

Piper Sandler

$296

Buy

8.73%

Upside

Reiterated

08/04/25

CME Group (CME) Gets a Buy from Piper Sandler

Benjamin Budish

Barclays

$299→$298

Hold

9.46%

Upside

Reiterated

07/24/25

CME Group (CME) Receives a Rating Update from a Top Analyst

Owen Lau

Oppenheimer

$300→$303

Buy

11.30%

Upside

Reiterated

07/24/25

Oppenheimer Sticks to Their Buy Rating for CME Group (CME)Raised our PT to $303 from $300.

Michael Cyprys

Morgan Stanley

$304→$303

Buy

11.30%

Upside

Reiterated

07/24/25

Positive Outlook for CME Group Driven by Risk Management Demand and Strong Financial Position

Craig Siegenthaler

Bank of America Securities

$213→$212

Sell

-22.13%

Downside

Reiterated

07/23/25

Bank of America Securities Sticks to Its Sell Rating for CME Group (CME)

Patrick O'Shaughnessy

Raymond James

$306→$309

Buy

13.50%

Upside

Reiterated

07/23/25

Daniel Fannon

Jefferies

$288→$313

Buy

14.97%

Upside

Reiterated

07/14/25

CME Group (CME) PT Raised to $313 at JefferiesJefferies analyst Daniel Fannon raised the price target on CME Group (NASDAQ: CME) to $313.00 (from $288.00) while maintaining a Buy rating.

Hans Engel

Erste Group

―

Hold

―

Downgraded

05/23/25

CME Group downgraded to Hold from Buy at Erste GroupCME Group downgraded to Hold from Buy at Erste Group

Kevin Heal

Argus Research

$285→$308

Buy

13.14%

Upside

Reiterated

05/06/25

CME Group price target raised to $308 from $285 at ArgusCME Group price target raised to $308 from $285 at Argus

Stocks with the Highest Top Analyst Consensus in the Financial Sector

xxx

Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CME Group

1 Month

xxx

Success Rate

21/34 ratings generated profit

Average Return

+1.94%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 61.76% of your transactions generating a profit, with an average return of +1.94% per trade.

3 Months

xxx

Success Rate

25/34 ratings generated profit

Average Return

+3.85%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 73.53% of your transactions generating a profit, with an average return of +3.85% per trade.

1 Year

Daniel FannonJefferies

Success Rate

27/34 ratings generated profit

Average Return

+14.78%

reiterated a buy rating 3 months ago

Copying Daniel Fannon's trades and holding each position for 1 Year would result in 79.41% of your transactions generating a profit, with an average return of +14.78% per trade.

2 Years

xxx

Success Rate

30/34 ratings generated profit

Average Return

+32.59%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 88.24% of your transactions generating a profit, with an average return of +32.59% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CME Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CME has received 16 Buy Ratings, 13 Hold Ratings, and 3 Sell Ratings. CME average Analyst price target in the past 3 months is 286.33.

Each month's total comprises the sum of three months' worth of ratings.

CME Financial Forecast

CME Earnings Forecast

Next quarter’s earnings estimate for CME is $2.71 with a range of $2.58 to $2.94. The previous quarter’s EPS was $2.96. CME beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year CME has Preformed in-line its overall industry.

CME Sales Forecast

Next quarter’s sales forecast for CME is $1.56B with a range of $1.50B to $1.68B. The previous quarter’s sales results were $1.69B. CME beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year CME has Preformed in-line its overall industry.

CME Stock Forecast FAQ

What is CME’s average 12-month price target, according to analysts?

Based on analyst ratings, CME Group’s 12-month average price target is 286.33.

What is CME’s upside potential, based on the analysts’ average price target?

CME Group has 5.18% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CME a Buy, Sell or Hold?

CME Group has a consensus rating of Moderate Buy which is based on 6 buy ratings, 4 hold ratings and 2 sell ratings.

What is CME Group’s price target?

The average price target for CME Group is 286.33. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $313.00 ,the lowest forecast is $212.00. The average price target represents 5.18% Increase from the current price of $272.24.

What do analysts say about CME Group?

CME Group’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of CME?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

CME Group (CME) Stock Forecast & Price Target

CME Analyst Ratings

CME Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CME Group

CME Analyst Recommendation Trends

CME Financial Forecast

CME Earnings Forecast

CME Sales Forecast

CME Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts